Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non–ST Elevation Myocardial Infarction

BACKGROUND: Despite guideline recommendations, a significant number of patients with non–ST elevation myocardial infarction (NSTEMI) do not receive dual antiplatelet therapy (DAPT) before angiography “pretreatment.” While there may be valid clinical reasons to not pretreat, such as concern for bleed...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafiq, Ali, Valle, Javier, Jang, Jae‐Sik, Qintar, Mohammed, Gosch, Kensey, Cohen, David J., Singh, Mandeep, Bach, Richard, Spertus, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937284/
https://www.ncbi.nlm.nih.gov/pubmed/27287700
http://dx.doi.org/10.1161/JAHA.116.003576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937284/
https://www.ncbi.nlm.nih.gov/pubmed/27287700
http://dx.doi.org/10.1161/JAHA.116.003576

Ejemplares similares